Directory Profile

Meagan  Whisenant

Meagan Whisenant, PhD, RN

Assistant Professor
Department of Research
SON 580E
View Curriculum Vitae

Dr. Whisenant has worked in oncology nursing for more than 15 years, in both inpatient and outpatient settings. Dr. Whisenant completed a NINR T32 funded Postdoctoral Fellowship in Interdisciplinary Research in Cancer, Aging, and End of Life Care at the University of Utah, College of Nursing and a Hawn Foundation Postdoctoral Fellowship at The University of Texas MD Anderson Cancer Center Department of Symptom Research. Dr. Whisenant studies symptoms associated with cancer disease and treatment. Her work involves studying the measurement of cancer disease- and treatment-related symptoms, variability in symptom trajectories, and methods for implementing routine symptom monitoring and management in clinical care, including patient-reported outcomes (PRO) instrument development and testing. She utilizes both qualitative and quantitative methods to learn about the symptom experience from the patient and family caregiver perspective and consider approaches for monitoring and managing symptoms across the cancer trajectory.  

Dr. Whisenant’s current focus is to improve cancer patient outcomes by developing a program of research focused on describing the symptom burden of cancer and methods for implementing routine symptom monitoring and management in cancer care using PRO measures. She is working on determining whether clinical, demographic, or genetic factors may distinguish symptom trajectory groups as well as modeling symptom trajectories in various cancer populations. Identifying distinct symptom trajectories and describing correlates of those trajectories may assist clinicians in targeting symptom management strategies for those most at risk for moderate or severe symptom experiences. Symptom monitoring and management has demonstrated improved cancer patient outcomes, yet best practices have not been established. Collection of symptom data is complicated by the dynamic nature of symptoms, the need for complex data management systems, and the timing of cancer symptoms, which often occur in the home setting and are not reported to clinicians. The use of disease-specific validated questionnaires in capturing PROs is critical for facilitating individualized symptom monitoring, management and treatment decisions. Dr. Whisenant is studying methods for capturing symptom-related data using PRO measures and studying patient-provider communication about symptoms in the outpatient setting.

Related News Items

Publication: Caregiver bereavement following the death of glioma patients (May 2022)

Advancing HIV research and education (Apr 2022)

Publication: Characterization of symptoms and symptom clusters for type 2 diabetes mellitus using a large nationwide EHR database (Mar 2022)

Publication: Identification of breast cancer survivors with high symptom burden (Dec 2021)

Publication: Analysis of symptom communication in women with breast cancer receiving treatment (Dec 2021)

Publication: The unique symptom burden of patients receiving CAR T-cell therapy (Dec 2021)

Cizik School of Nursing Researcher to Study Symptom Management of HIV Positive Patients (Oct 2021)

Publication: Patient-reported symptom and functioning status during the first 12 months after CAR T-cell therapy for hematological malignancies (Sep 2021)

Publication: Preferences of Individuals with Cancer for Patient-Reported Outcome Measures (Feb 2021)

Grant launches research into COVID-19 symptoms among cancer patients (Aug 2020)

(Publication) What Do Patients With Non–Small-Cell Lung Cancer Experience? Content Domain for the MD Anderson Symptom Inventory for Lung Cancer (Jul 2020)